COMMENTING ON THE CONCENTRATION OF AFP, AFP-L3, PIVKA II AND CHARACTERISTICS OF ABDOMINAL ULTRASOUND IN HEPATITIS B PATIENTS AT BACH MAI HOSPITAL
Main Article Content
Abstract
Aim: commenting on the concentration of AFP, AFP-L3, PIVKA II and characteristics of abdominal ultrasound in hepatitis B patients at Bach Mai hospital. Patients and methods: Prospective study of 311 hepatitis B patients from October 2019 to March 2021. Results: The most common age group was 41-70 years old (68, 5%). The average age was 48.7±12.3 years old, the disease was more common in men than women (2.5 times). The most common clinical symptoms include: Anorexia (25.7%), fatigue (32.5%), right lower quadrant abdominal pain (16.7%), abdominal distension (16.7%), jaundice (17.4%). 77.5% of patients did not have cirrhosis, and 22.5% of patients had cirrhosis. 2,3% of patients had both hepatitis B and C. Median of AFP, AFP-L3, PIVKA in the elevated group are 17.2 ng/mL; 9.4%; 24.0 mAU/mL, respectively. 23 patients had liver tumors (7.4%) of which 78.3% of tumors are less than 3 cm. All tumor lesions are benign. Conclusion: AFP, AFP-L3, PIVKA levels can be increased in hepatitis B with/without cirrhosis but not high. In this group, we should follow up regularly to detect liver cancer.
Article Details
Keywords
Hepatitis B, abdominal ultrasound, AFP, AFP-L3, PIVKA
References
2. Trần Bảo Nghi (2016). Nghiên cứu xơ hóa gan ở bệnh nhân bệnh gan mạn bằng đo đàn hồi gan thoáng qua đối chiếu với mô bệnh học. Luận án tiến sỹ y học, Đại học Y dược Huế.
3. Gabriele Ricco, Chiara Cosma, Giorgio Bedogni et al (2020), Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma. Cancer Biomark, 2020 29(2):189-196.
4. Robert J Wong, Aijaz Ahmed , Robert G Gish (2015), Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders, Clin Liver Dis, 2015, May;19(2):309-23.
5. S. Berhane, H. Toyoda, T. Tada et al (2016). Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. Clin Gastroenterol Hepatol, 14 (6), 875-886.e876.
6. Chih-Wei Yen , Yuan-Hung Kuo , Jing-Houng Wang et al (2018), Did AFP-L3 save ultrasonography in community screening? Kaohsiung J Med Sci, 2018 Oct;34(10):583-587.